Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 52, Issue 9, Pages 3398-3407Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00149-08
Keywords
-
Categories
Funding
- Cerexa, Inc. (Alameda, CA)
- Forest Laboratories, Inc
Ask authors/readers for more resources
This study evaluated the in vitro activity of ceftaroline, a novel cephalosporin with broad-spectrum activity against gram-negative and -positive pathogens, against 4,151 recent clinical isolates collected in the United States. Ceftaroline was very potent against bacteria found in community- and hospital-acquired infections, including methicillin-resistant Staphylococcus aureus, multidrug-resistant Streptococcus pneumoniae, and common Enterobacteriaceae spp.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available